Mortality among adults with cancer undergoing chemotherapy or immunotherapy and infected with COVID-19
Importance Large cohorts of patients with active cancers and COVID-19 infection are
needed to provide evidence of the association of recent cancer treatment and cancer type …
needed to provide evidence of the association of recent cancer treatment and cancer type …
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
J García-Suárez, J de la Cruz, Á Cedillo… - Journal of hematology & …, 2020 - Springer
Background Patients with cancer have been shown to have a higher risk of clinical severity
and mortality compared to non-cancer patients with COVID-19. Patients with hematologic …
and mortality compared to non-cancer patients with COVID-19. Patients with hematologic …
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Background Data on patients with COVID-19 who have cancer are lacking. Here we
characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify …
characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify …
Outcomes of COVID-19 in patients with cancer: report from the National COVID Cohort Collaborative (N3C)
PURPOSE Variation in risk of adverse clinical outcomes in patients with cancer and COVID-
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …
19 has been reported from relatively small cohorts. The NCATS'National COVID Cohort …
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …
improved in terms of disease management and capacity is yet to be defined. Objective To …
Evaluation of COVID-19 mortality and adverse outcomes in US patients with or without cancer
Importance As the COVID-19 pandemic continues, understanding the clinical outcomes of
patients with cancer and COVID-19 has become critically important. Objective To compare …
patients with cancer and COVID-19 has become critically important. Objective To compare …
Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta‐analysis of cohort studies
Background Heterogeneous evidence exists on the effect of coronavirus disease 2019
(COVID‐19) on the clinical outcomes of patients with cancer. Methods A systematic review …
(COVID‐19) on the clinical outcomes of patients with cancer. Methods A systematic review …
Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study
NR Fillmore, J La, RE Szalat, DP Tuck… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Emerging data suggest variability in susceptibility and outcome to coronavirus
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …
disease 2019 (COVID-19) infection. Identifying risk factors associated with infection and …
Rates of COVID-19–related outcomes in cancer compared with noncancer patients
L Sun, S Surya, AN Le, H Desai, A Doucette… - JNCI Cancer …, 2021 - academic.oup.com
Cancer patients are a vulnerable population postulated to be at higher risk for severe
coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and …
coronavirus disease 2019 (COVID-19) infection. Increased COVID-19 morbidity and …